Cargando…

Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis

BACKGROUND: The immune and bone systems are closely linked via cytokine cross-talk. This interdisciplinary field of research is referred to as osteoimmunology and pertains to inflammatory and osteoarticular diseases that feature the primary expression of tumor necrosis factor-alpha (TNF-α) and IL-6....

Descripción completa

Detalles Bibliográficos
Autores principales: Lechner, Johann, Rudi, Tatjana, von Baehr, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233471/
https://www.ncbi.nlm.nih.gov/pubmed/30519117
http://dx.doi.org/10.2147/CCIDE.S184498
_version_ 1783370568554250240
author Lechner, Johann
Rudi, Tatjana
von Baehr, Volker
author_facet Lechner, Johann
Rudi, Tatjana
von Baehr, Volker
author_sort Lechner, Johann
collection PubMed
description BACKGROUND: The immune and bone systems are closely linked via cytokine cross-talk. This interdisciplinary field of research is referred to as osteoimmunology and pertains to inflammatory and osteoarticular diseases that feature the primary expression of tumor necrosis factor-alpha (TNF-α) and IL-6. OBJECTIVE: Are there bone resorptive processes wherein chronic inflammatory conditions are not linked to TNF-α and IL-6 expression, but rather to the expression of other cytokines? MATERIALS AND METHODS: A comprehensive literature search was performed in PubMed Central. DISCUSSION: Although all diseases with cytokines involved in bone resorption (TNF-α and IL-6) are at the forefront of destructive inflammatory processes, there is one exception in the literature: fatty oxide osteoporosis/osteolysis in the jawbone (FDOJ), which is associated with significant bone softening. However, it should be noted that TNF-α and IL-6 fall below the levels found in a healthy jawbone in this condition. Another conspicuous finding is that there is a nearly 35-fold overexpression of the chemokine RANTES/CCL5 (R/C) in all FDOJ cases studied thus far in the literature. CONCLUSION: FDOJ appears to represent a unique cytokine and inflammatory pattern from osteolysis in the body. R/C can be defined as the dominant carrier of a “maxillomandibular osteoimmunology”.
format Online
Article
Text
id pubmed-6233471
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62334712018-12-05 Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis Lechner, Johann Rudi, Tatjana von Baehr, Volker Clin Cosmet Investig Dent Review BACKGROUND: The immune and bone systems are closely linked via cytokine cross-talk. This interdisciplinary field of research is referred to as osteoimmunology and pertains to inflammatory and osteoarticular diseases that feature the primary expression of tumor necrosis factor-alpha (TNF-α) and IL-6. OBJECTIVE: Are there bone resorptive processes wherein chronic inflammatory conditions are not linked to TNF-α and IL-6 expression, but rather to the expression of other cytokines? MATERIALS AND METHODS: A comprehensive literature search was performed in PubMed Central. DISCUSSION: Although all diseases with cytokines involved in bone resorption (TNF-α and IL-6) are at the forefront of destructive inflammatory processes, there is one exception in the literature: fatty oxide osteoporosis/osteolysis in the jawbone (FDOJ), which is associated with significant bone softening. However, it should be noted that TNF-α and IL-6 fall below the levels found in a healthy jawbone in this condition. Another conspicuous finding is that there is a nearly 35-fold overexpression of the chemokine RANTES/CCL5 (R/C) in all FDOJ cases studied thus far in the literature. CONCLUSION: FDOJ appears to represent a unique cytokine and inflammatory pattern from osteolysis in the body. R/C can be defined as the dominant carrier of a “maxillomandibular osteoimmunology”. Dove Medical Press 2018-11-09 /pmc/articles/PMC6233471/ /pubmed/30519117 http://dx.doi.org/10.2147/CCIDE.S184498 Text en © 2018 Lechner et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Lechner, Johann
Rudi, Tatjana
von Baehr, Volker
Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis
title Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis
title_full Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis
title_fullStr Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis
title_full_unstemmed Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis
title_short Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis
title_sort osteoimmunology of tumor necrosis factor-alpha, il-6, and rantes/ccl5: a review of known and poorly understood inflammatory patterns in osteonecrosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233471/
https://www.ncbi.nlm.nih.gov/pubmed/30519117
http://dx.doi.org/10.2147/CCIDE.S184498
work_keys_str_mv AT lechnerjohann osteoimmunologyoftumornecrosisfactoralphail6andrantesccl5areviewofknownandpoorlyunderstoodinflammatorypatternsinosteonecrosis
AT ruditatjana osteoimmunologyoftumornecrosisfactoralphail6andrantesccl5areviewofknownandpoorlyunderstoodinflammatorypatternsinosteonecrosis
AT vonbaehrvolker osteoimmunologyoftumornecrosisfactoralphail6andrantesccl5areviewofknownandpoorlyunderstoodinflammatorypatternsinosteonecrosis